Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortAnti-IL-5 antibody for severe eosinophilic asthma.Anti-IgE injection for allergic asthma and chronic hives.
Body systemLungs & BreathingLungs & Breathing
Drug classAsthma biologicsAsthma biologics
SupplyPrescription onlyPrescription only
Main usesSevere eosinophilic asthma, Nasal polyps, Eosinophilic granulomatosis with polyangiitisSevere allergic asthma, Chronic spontaneous urticaria (hives), Nasal polyps, Food allergy (US)
How it worksLowers a type of white cell that drives severe asthma.Blocks the allergy antibody IgE.
Starts workingWeeks to monthsWeeks to months
Half-lifeAbout 16–22 daysAbout 26 days
Typical adult dose100 mg subcutaneously every 4 weeks for asthma.75–600 mg every 2 or 4 weeks, based on body weight and IgE level for asthma; 150–300 mg every 4 weeks for hives.
FormsSubcutaneous injectionSubcutaneous injection
Common side effectsHeadache, Injection site reactions, Back pain, TirednessInjection site reactions, Headache, Sore throat, Joint pain
Serious side effectsAllergic reactions, Shingles, Parasite infectionsAnaphylaxis (rare), Parasite infection risk, Heart or stroke events (possible)
Don't take ifPrevious severe hypersensitivity to mepolizumabPrevious anaphylaxis to omalizumab
AlcoholUsually no problem in moderation. No known interaction.Usually no problem in moderation. No known interaction.
PregnancyUse with cautionLimited data.Use with cautionUsed if needed; data do not show harm.
BreastfeedingGenerally considered safeAntibodies pass into milk in small amounts.Generally considered safeAntibodies pass into milk in small amounts.
In use since——
Brand namesUnited States: NucalaUnited Kingdom: NucalaIndia: NucalaUnited States: XolairUnited Kingdom: XolairIndia: Xolair, Omalizumab (generic)
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H
ATC codeR03DX09R03DX05

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker